rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Dana Lynn Jacoby

Director

Company insider

Files Form 4 as: Director, Biote.

In numbers

Trades disclosed
25
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
26 May 2022
Last trade
12 May 2026
Last filed
13 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BTMD BioteDirector · Pharmaceuticals · last 12 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
12 May 2026filed 13 May 2026BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—37,777 at $0.00filing
12 May 2026filed 13 May 2026BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—130,000 at $0.00filing
12 May 2026filed 13 May 2026BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—37,777 at $0.00filing
12 May 2026filed 13 May 2026BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—130,000 at $0.00filing
13 May 2025filed 14 May 2025BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code M—12,994 at $0.00filing
13 May 2025filed 14 May 2025BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—21,587 at $0.00filing
13 May 2025filed 14 May 2025BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—104,547 at $0.00filing
13 May 2025filed 14 May 2025BTMD BiotePharmaceuticalsSEC FORM 4 Code M—12,994filing
21 May 2024filed 23 May 2024BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code M—11,595 at $0.00filing
21 May 2024filed 23 May 2024BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—12,994 at $0.00filing
21 May 2024filed 23 May 2024BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—65,258 at $0.00filing
21 May 2024filed 23 May 2024BTMD BiotePharmaceuticalsSEC FORM 4 Code M—11,595filing
30 Jun 2023filed 5 Jul 2023BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code M—6,058filing
30 Jun 2023filed 5 Jul 2023BTMD BiotePharmaceuticalsSEC FORM 4 Code M—6,058filing
17 May 2023filed 19 May 2023BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—11,595 at $0.00filing
17 May 2023filed 19 May 2023BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code A—46,809 at $0.00filing
31 Mar 2023filed 4 Apr 2023BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code M—9,844filing
31 Mar 2023filed 4 Apr 2023BTMD BiotePharmaceuticalsSEC FORM 4 Code M—9,844filing
31 Dec 2022filed 4 Jan 2023BTMD Bioteoption or derivative · PharmaceuticalsSEC FORM 4 Code M—9,844filing
31 Dec 2022filed 4 Jan 2023BTMD BiotePharmaceuticalsSEC FORM 4 Code M—9,844filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Marc D. BeerExecutive Chairman · Executive Chairman at biote, filing Form 4 there in the last year
Robert Charles PetersonInterim CEO · Interim CEO at biote, filing Form 4 there in the last year
Bret ChristensenDirector · Director at biote, filing Form 4 there in the last year
Andrew R. HeyerDirector · Director at biote, filing Form 4 there in the last year
Debra L. MorrisDirector · Director at biote, filing Form 4 there in the last year